Montrusco Bolton Investments Inc. lowered its position in shares of Danaher Co. (NYSE:DHR) by 2.6% in the 2nd quarter, Holdings Channel.com reports. The fund owned 341,070 shares of the conglomerate’s stock after selling 8,969 shares during the quarter. Danaher comprises approximately 3.1% of Montrusco Bolton Investments Inc.’s investment portfolio, making the stock its 11th largest position. Montrusco Bolton Investments Inc.’s holdings in Danaher were worth $47,911,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. State of Wisconsin Investment Board increased its position in shares of Danaher by 12.9% during the first quarter. State of Wisconsin Investment Board now owns 692,865 shares of the conglomerate’s stock valued at $91,472,000 after acquiring an additional 79,287 shares in the last quarter. Mitchell Capital Management Co. grew its position in Danaher by 20.7% in the 1st quarter. Mitchell Capital Management Co. now owns 12,174 shares of the conglomerate’s stock worth $1,607,000 after purchasing an additional 2,088 shares during the period. Rehmann Capital Advisory Group grew its position in Danaher by 11.1% in the 1st quarter. Rehmann Capital Advisory Group now owns 2,014 shares of the conglomerate’s stock worth $266,000 after purchasing an additional 202 shares during the period. Capital Advisors Ltd. LLC grew its position in Danaher by 527.5% in the 2nd quarter. Capital Advisors Ltd. LLC now owns 320 shares of the conglomerate’s stock worth $46,000 after purchasing an additional 269 shares during the period. Finally, Findlay Park Partners LLP grew its position in Danaher by 0.9% in the 1st quarter. Findlay Park Partners LLP now owns 4,635,000 shares of the conglomerate’s stock worth $611,913,000 after purchasing an additional 40,000 shares during the period. 79.49% of the stock is owned by institutional investors.

A number of equities research analysts have commented on DHR shares. Wolfe Research started coverage on shares of Danaher in a research report on Thursday, May 30th. They issued an “outperform” rating for the company. Argus lifted their target price on shares of Danaher to $165.00 and gave the stock a “buy” rating in a research report on Tuesday, July 23rd. Royal Bank of Canada set a $134.00 target price on shares of Danaher and gave the stock a “hold” rating in a research report on Friday, July 19th. Piper Jaffray Companies lifted their target price on shares of Danaher from $148.00 to $153.00 and gave the stock a “neutral” rating in a research report on Thursday, July 18th. Finally, Robert W. Baird lifted their target price on shares of Danaher from $131.00 to $148.00 and gave the stock an “outperform” rating in a research report on Friday, July 19th. Three investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Danaher has a consensus rating of “Buy” and an average price target of $143.54.

In other news, insider Brian W. Ellis sold 1,010 shares of Danaher stock in a transaction on Friday, July 26th. The shares were sold at an average price of $144.04, for a total transaction of $145,480.40. Following the transaction, the insider now owns 20,889 shares in the company, valued at approximately $3,008,851.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP William K. Daniel sold 7,534 shares of Danaher stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $131.27, for a total transaction of $988,988.18. Following the transaction, the executive vice president now owns 115,778 shares in the company, valued at approximately $15,198,178.06. The disclosure for this sale can be found here. Insiders have sold a total of 361,850 shares of company stock worth $49,587,520 in the last quarter. Corporate insiders own 11.40% of the company’s stock.

Shares of Danaher stock traded up $1.53 on Monday, hitting $141.88. 35,237 shares of the company’s stock were exchanged, compared to its average volume of 2,195,097. The company has a 50-day simple moving average of $141.37 and a 200-day simple moving average of $131.56. The stock has a market capitalization of $98.42 billion, a PE ratio of 31.26, a PEG ratio of 2.48 and a beta of 0.94. Danaher Co. has a 1 year low of $94.59 and a 1 year high of $145.50. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.91 and a current ratio of 2.32.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.15 by $0.04. The business had revenue of $5.16 billion for the quarter, compared to analysts’ expectations of $5.09 billion. Danaher had a net margin of 12.22% and a return on equity of 11.53%. The company’s revenue was up 3.5% compared to the same quarter last year. During the same quarter last year, the company posted $1.15 EPS. On average, analysts expect that Danaher Co. will post 4.79 EPS for the current fiscal year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Featured Story: Google Finance Portfolio Workaround

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.